Biostage has created a product that leading surgeons describe as, “revolutionary, “a breakthrough in tissue engineering and regenerative medicine” and that “would have considerable clinical use”.  - all quotes by top surgeons, from Massachusetts General Hospital, Mayo Clinic and Connecticut Children’s Medical Center.

Stock Information
Press Releases
Mar 1, 2023

Existing Board member Jerry He to replace David Green as Chairman and Chief Executive Officer; David Green to remain on the Board and support transition HOLLISTON, Mass., March 1, 2023 /PRNewswire/ --

Jan 12, 2023

Biostage removes Interim qualification from Mr. Green's title, making him Chief Executive Officer. HOLLISTON, Mass., Jan. 12, 2023 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the...

Dec 28, 2022

IQVIA was selected because of its dedicated gastrointestinal team and depth of experience in running cell-therapy clinical trials. HOLLISTON, Mass., Dec. 28, 2022 /PRNewswire/ -- Biostage, Inc....

More >

Contact Us

Biostage, Inc.
84 October Hill Road
Suite 11
Holliston, Massachusetts 01746
United States

Phone: 774-233-7300
Toll Free: 855-209-3104
Fax: 774-233-7302

Investor Presentation

Download PDF

Fact Sheet